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Whichmolecular events control the initiation of a T cell response? In this issue of Immunity, Huse et al.
(2007) describe a photoactivatable agonist that will substantially improve our ability to investigate
this phenomenon.Huse et al. (2007) have made use of
a new photoreleasable agonist pep-
tide, NPE-MCC, that binds to MHC
class II molecules I-Ek. The peptide
called MCC (a fragment of moth cyto-
chrome c) associated with I-Ek cannot
be recognized by 5C.C7 T cells, unless
the NPE-MCC liaison has been disrup-
ted by a UV flash. With this tool, it is
now possible to precisely set the time
at which antigen is recognized (time
resolution < 1 s) and to determine
where on the antigen-presenting cell
stimulation occurred (spatial resolu-
tion < 3 mm).
Most of the photoactivation experi-
ments by Huse et al. (2007) were per-
formed by following the response of T
cells interacting with a poly-L-lysine-
coated glass surface to which pep-
tide-MHC complexes (pMHC) and the
adhesion molecule ICAM-1 were at-
tached (Figure 1). Adhesion was pro-
moted by including MHC I antibodies
to the glass surface. In a few experi-
ments, the response was triggered at
the synapse between a T cell and an
antigen-presenting cell, a B cell line.
In both settings, a Ca2+ response was
triggered 6–7 s after uncaging a large
amount of antigen. A longer delay
was observed for lower antigen con-
centrations or when coactivation by
CD4 was blocked with a CD4 anti-
body.
The consequences of this stimula-
tion were further followed with two
additional readouts: the synaptic re-
cruitment of the fluorescent adaptor
Grb2-GFP and that of the fluorescent
probe C1-YFP, C1 being the cystein-
rich domain (CRD) of the protein ki-
nase PKCq that binds to diacylglycerol6 Immunity 27, July 2007 ª2007 Elsevier(DAG), as do other CRDs such as that
of the protein kinase PKD (Spitaler
et al., 2006). At large pMHC density,
the kinetics of Ca2+ increase and of
C1 recruitment were very similar. This
fits with the notion that both depend
on the activity of the phospholipase
PLC-g, which leads to the production
of inositol trisphosphate (IP3) for the
Ca2+ response and DAG for PKCq re-
cruitment and activation. A paradoxi-
cal observation is that for less intense
stimuli, the delay preceding the Ca2+
response increases, but that preced-
ing DAG detection does not. This
might be due to the fact that the IP3 de-
pendence of the Ca2+ response is not
linear, but depends on the third power
of IP3 concentration, the opening of
one receptor-channel presumably re-
quiring the binding of three IP3 mole-
cules (Meyer et al., 1988).
Grb2 is generally viewed as being
recruited on phosphorylated LAT and
may therefore serve to detect LAT
phosphorylation (Burack et al., 2002).
However, the colocalization of fluores-
cent Grb2 and LAT-GFP was only par-
tial, indicating that LAT is not the only
site of Grb2 recruitment. After photo-
activating the agonist, Grb2 was re-
cruited at the synapse several sec-
onds before the Ca2+ response, and
the delay preceding Grb2 recruitment
appeared insensitive to the stimulus
intensity. It is noteworthy that in some
images, Grb2-GFP clusters were visi-
ble prior to agonist stimulation, possi-
bly as a result of T cell priming by ad-
hesion. Such preassembled partial
signaling units might contribute to the
rapidity with which the signaling
events revealed by Grb2 recruitmentInc.occurred. It would be interesting to
look for a possible correspondence
between such preassembled signalo-
somes and TCR microclusters that
may be detected by electron micros-
copy before T cell activation (Lillemeier
et al., 2006; Schamel et al., 2005).
Translocation of the microtubule-or-
ganizing center (MTOC) or centrosome
toward the synapse started approxi-
mately 1 min after the other signaling
events were detected. This delay may
correspond to the following sequence
of events: (1) TCR-induced building
up of a platform for microtubule an-
choring; (2) trapping of a substantial
fraction of growing microtubules by
this platform; and (3) pulling the cen-
trosome to this synaptic site of micro-
tubule anchoring (Figure 1).
The authors have also performed
a series of experiments in which two
sequential stimuli were applied 1–2
min apart, at two different parts of the
cell. Different combinations of pulse
intensities were used, the first one be-
ing either more or less intense than the
second one. One readout for these
double stimulations was the reorienta-
tion of the MTOC after the second
stimulus. The whole set of data fits
with the interpretation that a second
localized stimulation leads to a reorien-
tation of the MTOC only if this stimula-
tion allows the formation of a second
anchoring platform larger or more effi-
cient than the first one.
Another readout for the double stim-
ulation is the occurrence of a partial
desensitization of the second re-
sponse. With two pulses of identical
intensity, some aspects of the T cell re-
sponse were reduced after the second
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PreviewsFigure 1. Signaling Events in T Cell Interacting with Photoactivatable Agonist Bound to MHC II Molecules on Lipid Bilayer
T cells are first primed by adhesion. After the ultraviolet flash has created a zone of active MHC-peptide complexes (blue), within less than 10 s
the Grb2 adaptor is recruited locally, followed by DAG and by a global Ca2+ response. The formation of this initial signalosome (red) leads to the
formation of a platform (gray) on which microtubules may be anchored. After 1 min, their number is large enough to pull the MTOC in the vicinity
of this anchoring zone.stimulation, demonstrating that mole-
cules associated with negative signal-
ing diffuse in the whole cell after a local
stimulation. This diffusion of negative
signaling contrasts with the very lim-
ited spreading of Grb2 or C1 (DAG) ac-
cumulation after a local stimulation.
Negative signaling probably affected
PLC-g activation, because it reduced
both DAG clustering and IP3-depen-
dent Ca2+ responses. However, it did
not affect Grb2 recruitment, at least
during the first minutes after stimula-
tion.
We can already foresee that a photo-
activatable agonist will be very useful
for better understanding different as-
pects of TCR signaling and its extraor-
dinary sensitivity. Indeed, a remarkable
feature of T cells is that activation of
a single receptor (possibly, within an
array of receptors) is sufficient to trig-
ger a response in the cell (Irvine et al.,
2002), whereas in most other cell
types, several tens or hundreds of re-
ceptors must be activated simulta-
neously in order to elicit a cellular re-
sponse. This is true for the BCR in
B cells or for neurotransmitter recep-
tors in the nervous system. The only
other exception are photoreceptors,
in which activation of a single rhodop-
sin molecule suffices to trigger a cellu-
lar response. This emphasizes that, like
photoreceptors, T cells must be en-
dowed with a very sensitive detection
system, with powerful amplification
loops. It is therefore important to be
able to probe this signaling cascade
under conditions as close as possibleto physiological stimuli, i.e., upon
interaction with antigen-presenting
cells. The best time resolution for
TCR signaling reached so far has
been with Jurkat (T cells devoid of sev-
eral phosphatases) stimulated with
CD3 antibodies as a stimulus (Hout-
man et al., 2005). Obviously, a very in-
tense stimulation with a high-affinity li-
gand is not best suited for probing the
high sensitivity and amplification loops
of a signaling cascade. Working with
real antigen-presenting cells, with
a sharp start for the stimulation made
possible with a photoactivatable ago-
nist, will constitute a much more ap-
propriate experimental system.
An additional advantage of the sys-
tem is that it allows one to separate
the early phase of conjugate formation
from the antigen-specific stimulation
itself. This is important because this
initial adhesion is responsible for sen-
sitizing the T cell for TCR signaling. In
the experiments of Huse et al. (2007),
both adhesion and sensitization were
likely to be promoted by adding
MHC I antibodies to the glass surface.
This adhesion-induced T cell priming
makes it possible for T cells to be acti-
vated by a single agonist peptide
(Irvine et al., 2002) or by soluble
monomeric MHC-peptide complexes
(Randriamampita et al., 2003). With
a photoactivatable agonist, it is now
possible to trigger an antigen-specific
T cell response after sensitization has
taken place.
The very high sensitivity of T cells for
detecting antigen thus requires a sen-Immsitizing phase, then positive-feedback
systems, that in turn impose the exis-
tence of negative signaling for avoid-
ing spurious activation that could arise
from random fluctuations in the local
number of signaling molecules.
Deciphering the mechanisms oper-
ating in the initiation of TCR signaling
should be greatly facilitated by the
use of this photoactivatable agonist,
especially if it is combined with new
fluorescent probes for measuring the
recruitment of signaling molecules, or
even enzymatic activities.
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